TSP48519-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K13274297


TSA198584-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297


TSA198630-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297


TSA198682-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297


TSA198732-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297


TSA198783-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297


TSA198835-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297


TSA198883-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297


TSA198928-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297


TSF399762-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 10.0 µM for 24.0 h


1 subfactor(s)
TSF399763-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 3.33 µM for 24.0 h


1 subfactor(s)
TSF399765-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.37 µM for 24.0 h


1 subfactor(s)
TSF399764-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 1.11 µM for 24.0 h


1 subfactor(s)
TSF399766-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.125 µM for 24.0 h


1 subfactor(s)
TSF399767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.04 µM for 24.0 h


1 subfactor(s)
TSF400077-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 10.0 µM for 24.0 h


1 subfactor(s)
TSF400078-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 3.33 µM for 24.0 h


1 subfactor(s)
TSF400079-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 1.11 µM for 24.0 h


1 subfactor(s)
TSF400080-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.37 µM for 24.0 h


1 subfactor(s)
TSF400081-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.125 µM for 24.0 h


1 subfactor(s)
TSF400082-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.04 µM for 24.0 h


1 subfactor(s)
TSF400394-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 10.0 µM for 24.0 h


1 subfactor(s)
TSF400399-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.04 µM for 24.0 h


1 subfactor(s)
TSF400395-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 3.33 µM for 24.0 h


1 subfactor(s)
TSF400396-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 1.11 µM for 24.0 h


1 subfactor(s)
TSF400397-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.37 µM for 24.0 h


1 subfactor(s)
TSF400398-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.125 µM for 24.0 h


1 subfactor(s)
TSF400711-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 1.11 µM for 24.0 h


1 subfactor(s)
TSF400712-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.37 µM for 24.0 h


1 subfactor(s)
TSF400709-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 10.0 µM for 24.0 h


1 subfactor(s)
TSF400710-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 3.33 µM for 24.0 h


1 subfactor(s)
TSF400713-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.125 µM for 24.0 h


1 subfactor(s)
TSF400714-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.04 µM for 24.0 h


1 subfactor(s)
TSF401026-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 3.33 µM for 24.0 h


1 subfactor(s)
TSF401025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 10.0 µM for 24.0 h


1 subfactor(s)
TSF401027-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 1.11 µM for 24.0 h


1 subfactor(s)
TSF401028-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.37 µM for 24.0 h


1 subfactor(s)
TSF401029-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.125 µM for 24.0 h


1 subfactor(s)
TSF401030-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.04 µM for 24.0 h


1 subfactor(s)
TSF401347-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.125 µM for 24.0 h


1 subfactor(s)
TSF401343-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 10.0 µM for 24.0 h


1 subfactor(s)
TSF401344-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 3.33 µM for 24.0 h


1 subfactor(s)
TSF401345-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 1.11 µM for 24.0 h


1 subfactor(s)
TSF401346-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.37 µM for 24.0 h


1 subfactor(s)
TSF401348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.04 µM for 24.0 h


1 subfactor(s)
TSF401663-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 10.0 µM for 24.0 h


1 subfactor(s)
TSF401664-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 3.33 µM for 24.0 h


1 subfactor(s)
TSF401665-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 1.11 µM for 24.0 h


1 subfactor(s)
TSF401666-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.37 µM for 24.0 h


1 subfactor(s)
TSF401667-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.125 µM for 24.0 h


1 subfactor(s)
TSF401668-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.04 µM for 24.0 h


1 subfactor(s)
TSF401982-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.04 µM for 24.0 h


1 subfactor(s)
TSF401978-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 3.33 µM for 24.0 h


1 subfactor(s)
TSF401977-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 10.0 µM for 24.0 h


1 subfactor(s)
TSF401979-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 1.11 µM for 24.0 h


1 subfactor(s)
TSF401980-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.37 µM for 24.0 h


1 subfactor(s)
TSF401981-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.125 µM for 24.0 h


1 subfactor(s)
TSS399770-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 10.0 µM for 24.0 h


TSS399771-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 3.33 µM for 24.0 h


TSS399773-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.37 µM for 24.0 h


TSS399772-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 1.11 µM for 24.0 h


TSS399774-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.125 µM for 24.0 h


TSS399775-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.04 µM for 24.0 h


TSS400085-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 10.0 µM for 24.0 h


TSS400086-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 3.33 µM for 24.0 h


TSS400087-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 1.11 µM for 24.0 h


TSS400088-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.37 µM for 24.0 h


TSS400089-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.125 µM for 24.0 h


TSS400090-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.04 µM for 24.0 h


TSS400402-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 10.0 µM for 24.0 h


TSS400407-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.04 µM for 24.0 h


TSS400403-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 3.33 µM for 24.0 h


TSS400404-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 1.11 µM for 24.0 h


TSS400405-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.37 µM for 24.0 h


TSS400406-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.125 µM for 24.0 h


TSS400719-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 1.11 µM for 24.0 h


TSS400720-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.37 µM for 24.0 h


TSS400717-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 10.0 µM for 24.0 h


TSS400718-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 3.33 µM for 24.0 h


TSS400721-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.125 µM for 24.0 h


TSS400722-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.04 µM for 24.0 h


TSS401034-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 3.33 µM for 24.0 h


TSS401033-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 10.0 µM for 24.0 h


TSS401035-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 1.11 µM for 24.0 h


TSS401036-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.37 µM for 24.0 h


TSS401037-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.125 µM for 24.0 h


TSS401038-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.04 µM for 24.0 h


TSS401355-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.125 µM for 24.0 h


TSS401351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 10.0 µM for 24.0 h


TSS401352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 3.33 µM for 24.0 h


TSS401353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 1.11 µM for 24.0 h


TSS401354-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.37 µM for 24.0 h


TSS401356-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.04 µM for 24.0 h


TSS401671-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 10.0 µM for 24.0 h


TSS401672-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 3.33 µM for 24.0 h


TSS401673-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 1.11 µM for 24.0 h


TSS401674-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.37 µM for 24.0 h


TSS401675-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.125 µM for 24.0 h


TSS401676-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.04 µM for 24.0 h


TSS401990-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.04 µM for 24.0 h


TSS401986-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 3.33 µM for 24.0 h


TSS401985-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 10.0 µM for 24.0 h


TSS401987-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 1.11 µM for 24.0 h


TSS401988-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.37 µM for 24.0 h


TSS401989-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.125 µM for 24.0 h



TSP48519 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K13274297 Public


https://clue.io/data/CMap2020#LINCS2020

Experimental design


No experimental design provided

Results


No results provided